The Ecstasy and Related Drugs Reporting System (EDRS) is a national drug monitoring system intended to identify emerging trends of local and national concern in illicit drug markets, and form part of Drug Trends.  

Pharmaceutical stimulants, such as methylphenidate (Concerta, Ritalin), dextroamphetamine and amphetamine (Adderall) and modafinil (Modavigil) are commonly prescribed to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. However, there has been commentary globally about the increasing non-medical use of pharmaceutical stimulants, especially amongst student populations to increase alertness, concentration, and memory. 

The aim of this paper is to analyse pharmaceutical stimulant use amongst a sample of people who regularly use ecstasy and/or other stimulants, from 2007-2021 and to examine non prescribed use amongst current students and non-students

Resources

Author(s)

Fiona Jones, Rachel Sutherland
Date Commenced
25 Aug 2022
Resource Type
Drug Trends Bulletins